Mitochondria and the Heart
The heart is an incredibly resilient and hard-working muscle. Over a lifetime, it pumps blood continuously — a task that requires an astonishing amount of energy. In fact, the heart is the organ with the highest energy demand in the body. It’s no surprise that cardiac muscle cells, or cardiomyocytes, are densely packed with mitochondria, which can occupy up to 35% of the cell’s volume.
As the “power plants” of the cell, mitochondria produce most of the ATP (the body’s energy molecule) that the heart needs to contract and relax with every beat. Without a constant and efficient supply of energy from mitochondria, the heart simply could not function.
The Crucial Role of Mitochondria in Heart Health
The heart is highly “flexible” in its energy use. Although its main fuel source is fatty acids, it can also use glucose, lactate, and other substrates. The ability of mitochondria to adapt to different energy sources is essential for cardiac health. Mitochondrial dysfunction, therefore, disrupts the normal flow of energy and is a key factor in the development and progression of heart disease.
Mitochondrial dysfunction in the heart can manifest in several ways:
Reduced Energy Production: Damaged or less efficient mitochondria cannot produce enough ATP. This weakens the heart muscle, preventing it from contracting with the force needed to pump blood effectively — a central problem in heart failure.
Increased Oxidative Stress: Mitochondrial dysfunction increases the production of reactive oxygen species (ROS), which damage heart cells, lipids, proteins, and mitochondrial DNA. This oxidative damage accelerates cellular aging and contributes to disease.
Programmed Cell Death (Apoptosis): Severe mitochondrial damage can trigger the cell’s “self-destruct” mechanism (apoptosis), leading to the loss of cardiomyocytes and a subsequent reduction in heart function.
The Link Between Mitochondria and Heart Diseases
Heart Failure: One of the most common heart diseases with a well-documented link to mitochondrial dysfunction. In heart failure, the heart progressively weakens and cannot pump blood efficiently. Numerous studies have shown that mitochondrial dysfunction, with reduced ATP production and increased oxidative stress, is a hallmark of patients with this condition.
Ischemic Heart Disease: Occurs when blood flow to the heart muscle is reduced, often due to blockage of the coronary arteries (a heart attack). During ischemia (lack of oxygen), mitochondria are severely damaged. After blood flow is restored, mitochondria can release large amounts of ROS, causing additional damage that may be more harmful than the ischemia itself — a phenomenon known as reperfusion injury.
Cardiomyopathies: Diseases of the heart muscle that make it harder for the heart to pump blood to the rest of the body. Many cardiomyopathies, especially those of genetic origin, are directly related to defects in mitochondrial function or energy production.
In Summary
Mitochondria are the engine of the heart. Their proper function is as vital to the heart as the oxygen it carries. Mitochondrial dysfunction is not only a consequence but also a driver of heart disease. Understanding this relationship opens the door to new therapeutic strategies, such as developing drugs that protect mitochondria or enhance their efficiency to fight these diseases.
Scientific Articles:
Mitochondrial Energy Metabolism in Heart Failure: A Question of Balance
PMCID: PMC1052011 | PMID: 15765136Mitochondrial Structure and Function in Human Heart Failure
https://doi.org/10.1161/CIRCRESAHA.124.323800Intercellular Mitochondrial Transfer: Therapeutic Implications for Energy Metabolism in Heart Failure
https://doi.org/10.1016/j.phrs.2024.107555Mitochondrial Dysfunction in Pathophysiology of Heart Failure
PMCID: PMC6118589 | PMID: 30124471Mitochondrial Dynamics: A Potential New Therapeutic Target for Heart Failure
https://doi.org/10.1016/j.rec.2011.05.022Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and Their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function
https://doi.org/10.1002/ejhf.3674Mitochondrial Dysfunction in Cardiovascular Diseases
https://doi.org/10.3390/ijms26051917Research Progress on the Relationship Between Mitochondrial Function and Heart Failure: A Bibliometric Study from 2002 to 2021
https://doi.org/10.3389/fmolb.2022.1036364